Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now
There’s no question that AI agents — those that can work autonomously and asynchronously behind the scenes in enterprise workflows — are the topic du jour in enterprise right now.
But there’s increasing concern that it’s all just that — talk, mostly hype, without much substance behind it.
Gartner, for one, observes that enterprises are at the “peak of inflated expectations,” a period just before disillusionment sets in because vendors haven’t backed up their talk with tangible, real-world use cases.
Still, that’s not to say that enterprises aren’t experimenting with AI agents and seeing early return on investment (ROI); global enterprises Block and GlaxoSmithKline (GSK), for their parts, are exploring proof of concepts in financial services and drug discovery.






